Product News and Software Release Notes

This page is dedicated to keeping Relegen’s customers up-to-date with product-specific news, software updates and links to release notes for the assetDNA, riskDNA, Unified Suite Cloud Platform and relegenDNA Mobile applications.

Product Update | relegenDNA Mobile (iOS)

February 14, 2020
Relegen has released new update for its new relegenDNA Mobile iOS application which is now available for download from the Apple App Store. This latest update for relegenDNA Mobile (v3.1.7) delivers over 16 fixes, security updates, performance enhancements and new features to the app’s core...

Product Update | relegenDNA Mobile (iOS)

December 19, 2019
Relegen has today released a new update for its new relegenDNA Mobile iOS application which is now available for download from the Apple App Store. This latest update for relegenDNA Mobile (v3.1.1) delivers over 30 fixes, security updates, performance enhancements and new features to the...

Product Update | relegenDNA Mobile (iOS)

October 8, 2019
Relegen has today released an updated version of its new relegenDNA Mobile iOS application which is now available for download from the Apple App Store. You can read the original product announcement regarding the launch of relegenDNA Mobile here. This latest update for relegenDNA Mobile...

Product Update | assetDNA · riskDNA · Unified Suite Cloud Platform

July 30, 2019
Relegen has today published the release notes for a number of software updates made to the assetDNA, riskDNA and Unified Suite cloud application. This document includes a consolidated summary of all updates published from 30 November, 2018 through to 24 July, 2019. Together they deliver...

Product Update | relegenDNA Mobile (iOS)

June 4, 2019
Relegen has today released an updated version of its relegenDNA Mobile iOS application which is now available for download from the Apple App Store. relegenDNA Mobile was officially released in May 2019, and this first update delivers over 70 fixes, security updates, performance enhancements and...